Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Dietary Supplement and Nonprescription Drug Consumer Protection Act
Client: HERBALIFE INTERNATIONAL OF AMERICA INC · Firm: HERBALIFE INTERNATIONAL OF AMERICA, INC.
1. Initiative to allow purchase of meal replacement products and certain dietary supplements under Health Savings and Flex Spending Accounts, HR1545 2. Mandatory reporting of serious adverse events for dietary supplements, S.3546
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HERBALIFE INTERNATIONAL OF AMERICA INC via HERBALIFE INTERNATIONAL OF AMERICA, INC.
2006 · year_end · YY
Tariff and non-tariff barriers to trade including regulatory and services barriers related to nutritional supplements and weight management products and the method of distribution
1. Initiative to allow purchase of meal replacement products and certain dietary supplements under Health Savings and Flex Spending Accounts, HR1545 2. Mandatory reporting of serious adverse events for dietary supplements, S.3546
Source: Senate LDA
FTC proposed business opportunity rule
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)